Media Summary: 00:00 - Meeting Begins 03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal 19:53 - Panel 1: Leveraging Learnings from ... One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Michele Vendruscolo, Director, Chemistry of Health Laboratory, Co-Director, Centre for Misfolding Diseases, University of ...

Expediting Drug Development Use Of - Detailed Analysis & Overview

00:00 - Meeting Begins 03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal 19:53 - Panel 1: Leveraging Learnings from ... One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Michele Vendruscolo, Director, Chemistry of Health Laboratory, Co-Director, Centre for Misfolding Diseases, University of ... Discover how this pivot could revolutionize the way we conduct research, The biology of the human body is complex; Novartis scientist Mark Bray describes how machines can help speed the science of

Join us for an engaging and informative Virtual Lunch & Learn series, where we will dive deep into the key aspects of American MedChem Nonprofit Corporation is committed to discover and develop small molecule-based

Photo Gallery

Expediting Drug Development: Use of ctDNA as an Early Endpoint
Novartis CEO discusses how AI will impact drug development
USE CASE - Expediting drug discovery for undruggable targets using AI
How are Medicines Discovered & Developed?
Drug Development and FDA Review Process
Drug discovery and development process
TechBio Revolution: Chris Gibson's Vision for Future of Toxicology & Drug Development (Extended)
97th SPSR Webinar on 'Expediting Drug Discovery & Development using AI: Opportunities & Challenges’
Revolutionizing drug discovery with artificial intelligence
Machine learning in action during drug discovery
Virtual Lunch & Learn: FDA Programs to Facilitate and Expedite Development of New Drugs
Expedited Programs for Drug Approvals
Sponsored
Sponsored
View Detailed Profile
Expediting Drug Development: Use of ctDNA as an Early Endpoint

Expediting Drug Development: Use of ctDNA as an Early Endpoint

00:00 - Meeting Begins 03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal 19:53 - Panel 1: Leveraging Learnings from ...

Novartis CEO discusses how AI will impact drug development

Novartis CEO discusses how AI will impact drug development

One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ...

Sponsored
USE CASE - Expediting drug discovery for undruggable targets using AI

USE CASE - Expediting drug discovery for undruggable targets using AI

Michele Vendruscolo, Director, Chemistry of Health Laboratory, Co-Director, Centre for Misfolding Diseases, University of ...

How are Medicines Discovered & Developed?

How are Medicines Discovered & Developed?

Have you ever wondered how

Drug Development and FDA Review Process

Drug Development and FDA Review Process

This is presented by Judy Heidebrink.

Sponsored
Drug discovery and development process

Drug discovery and development process

Discovering and bringing one new

TechBio Revolution: Chris Gibson's Vision for Future of Toxicology & Drug Development (Extended)

TechBio Revolution: Chris Gibson's Vision for Future of Toxicology & Drug Development (Extended)

Discover how this pivot could revolutionize the way we conduct research,

97th SPSR Webinar on 'Expediting Drug Discovery & Development using AI: Opportunities & Challenges’

97th SPSR Webinar on 'Expediting Drug Discovery & Development using AI: Opportunities & Challenges’

97th SPSR Webinar on '

Revolutionizing drug discovery with artificial intelligence

Revolutionizing drug discovery with artificial intelligence

The biology of the human body is complex;

Machine learning in action during drug discovery

Machine learning in action during drug discovery

Novartis scientist Mark Bray describes how machines can help speed the science of

Virtual Lunch & Learn: FDA Programs to Facilitate and Expedite Development of New Drugs

Virtual Lunch & Learn: FDA Programs to Facilitate and Expedite Development of New Drugs

Join us for an engaging and informative Virtual Lunch & Learn series, where we will dive deep into the key aspects of

Expedited Programs for Drug Approvals

Expedited Programs for Drug Approvals

Lisa Henderson, Editorial Director of

Expediting Drug Development for Children with Rare Diseases

Expediting Drug Development for Children with Rare Diseases

American MedChem Nonprofit Corporation is committed to discover and develop small molecule-based